Abdolmohamad Rostami, MD, PhD

Abdolmohamad Rostami, MD, PhD

Contact Dr. Rostami

901 Walnut Street
Fourth Floor
Philadelphia, PA 19107

(215) 955-8100
(215) 955-1390 fax

Most Recent Peer-reviewed Publications

  1. Generation of oligodendrocyte progenitor cells from mouse bone marrow cells
  2. Combination therapy with fingolimod and neural stem cells promotes functional myelination In vivo through a non-immunomodulatory mechanism
  3. The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation
  4. Distinct role of IL-27 in immature and LPS-induced mature dendritic cell-mediated development of CD4 + CD127 + 3G11 + regulatory T cell subset
  5. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity
  6. Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions
  7. Interaction of RNA-binding protein HuR and miR-466i regulates GM-CSF expression
  8. DAB 389 IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice
  9. Induction of peripheral tolerance in ongoing autoimmune inflammation requires interleukin 27 signaling in dendritic cells
  10. LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis
  11. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4 + regulatory T cell subpopulations mediated by 3G11 and CD127
  12. 1,25-Dihydroxyvitamin D3 suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation
  13. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair
  14. CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis
  15. Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence
  16. Selective depletion of CD11c + CD11b + dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE
  17. Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity
  18. Galectin-1 is essential for the induction of MOG 35–55 -based intravenous tolerance in experimental autoimmune encephalomyelitis
  19. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
  20. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4 + effector memory T cells